The Chinese expert consensus statement provides updated recommendations for managing dual antiplatelet therapy in patients with coronary artery disease.
Absolute Event Rate: 0% vs 0%
reviews the most remarkable paper published in the Journal over the last 3 months.
“对冠心病治疗来说,无论是以血栓事件为主要临床表现的急性期患者,还是在冠心病发展进展过程中其他各阶段患者,抗血小板治疗都是能够改善预后的非常重要的干预手段。”
Yaling Han (Thu,) reported a other. The Chinese expert consensus statement provides updated recommendations for managing dual antiplatelet therapy in patients with coronary artery disease.